Yamaoka-Tojo M - Search Results

1

Ezetimibe enhances and stabilizes anticoagulant effect of warfarin.

Hashikata T, Yamaoka-Tojo M, Kakizaki R, Nemoto T, Fujiyoshi K, Namba S, Kitasato L, Hashimoto T, Ishii S, Kameda R, Shimohama T, Tojo T, Ako J. Hashikata T, et al. Heart Vessels. 2017 Jan;32(1):47-54. doi: 10.1007/s00380-016-0832-z. Epub 2016 Apr 6. Heart Vessels. 2017. PMID: 27052207

2

Circulating levels of interleukin 18 reflect etiologies of heart failure: Th1/Th2 cytokine imbalance exaggerates the pathophysiology of advanced heart failure.

Yamaoka-Tojo M, Tojo T, Inomata T, Machida Y, Osada K, Izumi T. Yamaoka-Tojo M, et al. J Card Fail. 2002 Feb;8(1):21-7. doi: 10.1054/jcaf.2002.31628. J Card Fail. 2002. PMID: 11862579

3

C-reactive protein-induced production of interleukin-18 in human endothelial cells: a mechanism of orchestrating cytokine cascade in acute coronary syndrome.

Yamaoka-Tojo M, Tojo T, Masuda T, Machida Y, Kitano Y, Kurosawa T, Izumi T. Yamaoka-Tojo M, et al. Heart Vessels. 2003 Sep;18(4):183-7. doi: 10.1007/s00380-003-0719-7. Heart Vessels. 2003. PMID: 14520485

4

Central neurotranspeptide, alpha-melanocyte-stimulating hormone (alpha-MSH) is upregulated in patients with congestive heart failure.

Yamaoka-Tojo M, Tojo T, Shioi T, Masuda T, Inomata T, Izumi T. Yamaoka-Tojo M, et al. Intern Med. 2006;45(7):429-34. doi: 10.2169/internalmedicine.45.1546. Epub 2006 May 1. Intern Med. 2006. PMID: 16679696 Free article.

5

Beyond cholesterol lowering: pleiotropic effects of bile acid binding resins against cardiovascular disease risk factors in patients with metabolic syndrome.

Yamaoka-Tojo M, Tojo T, Izumi T. Yamaoka-Tojo M, et al. Curr Vasc Pharmacol. 2008 Oct;6(4):271-81. doi: 10.2174/157016108785909698. Curr Vasc Pharmacol. 2008. PMID: 18855715 Review.

6

Effects of ezetimibe add-on therapy for high-risk patients with dyslipidemia.

Yamaoka-Tojo M, Tojo T, Kosugi R, Hatakeyama Y, Yoshida Y, Machida Y, Aoyama N, Masuda T, Izumi T. Yamaoka-Tojo M, et al. Lipids Health Dis. 2009 Oct 12;8:41. doi: 10.1186/1476-511X-8-41. Lipids Health Dis. 2009. PMID: 19821987 Free PMC article.

7

Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease.

Yamaoka-Tojo M, Tojo T, Takahira N, Matsunaga A, Aoyama N, Masuda T, Izumi T. Yamaoka-Tojo M, et al. Cardiovasc Diabetol. 2010 May 14;9:17. doi: 10.1186/1475-2840-9-17. Cardiovasc Diabetol. 2010. PMID: 20470376 Free PMC article.

8

Ezetimibe and reactive oxygen species.

Yamaoka-Tojo M, Tojo T, Takahira N, Masuda T, Izumi T. Yamaoka-Tojo M, et al. Curr Vasc Pharmacol. 2011 Jan;9(1):109-20. doi: 10.2174/157016111793744652. Curr Vasc Pharmacol. 2011. PMID: 21044015 Review.

9

Circulating interleukin-18: A specific biomarker for atherosclerosis-prone patients with metabolic syndrome.

Yamaoka-Tojo M, Tojo T, Wakaume K, Kameda R, Nemoto S, Takahira N, Masuda T, Izumi T. Yamaoka-Tojo M, et al. Nutr Metab (Lond). 2011 Jan 20;8:3. doi: 10.1186/1743-7075-8-3. Nutr Metab (Lond). 2011. PMID: 21251304 Free PMC article.

10

Postprandial hyperglycemia and endothelial function in type 2 diabetes: focus on mitiglinide.

Kitasato L, Tojo T, Hatakeyama Y, Kameda R, Hashikata T, Yamaoka-Tojo M. Kitasato L, et al. Cardiovasc Diabetol. 2012 Jun 29;11:79. doi: 10.1186/1475-2840-11-79. Cardiovasc Diabetol. 2012. PMID: 22748110 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

132 results

Search Page

Filters